Xie Zhangli, Liao Liyi, Zhang Shuang, Hu Lin, Li Xuping
Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025 May 28;50(5):747-756. doi: 10.11817/j.issn.1672-7347.2025.240702.
Sympathectomy, as an emerging treatment method for cardiovascular diseases, has received extensive attention in recent years. Stereotactic radiotherapy (SRT), a precise and noninvasive therapeutic technique, has gradually been introduced into interventions targeting the sympathetic nervous system and has shown promising prospects in the management of cardiovascular conditions. Using three-dimensional imaging, SRT can accurately localize sympathetic ganglia and deliver high-energy radiation to disrupt nerve fibers, thereby achieving effects similar to conventional sympathectomy while reducing surgery-related complications and shortening recovery time. It also offers the advantages of being noninvasive and causing fewer adverse effects, and thus holds potential as an alternative to traditional approaches in the future. The integration of SRT with sympathectomy opens new avenues for the treatment of cardiovascular diseases and presents broad clinical application prospects.
交感神经切除术作为一种新兴的心血管疾病治疗方法,近年来受到了广泛关注。立体定向放射治疗(SRT)是一种精确的非侵入性治疗技术,已逐渐被引入针对交感神经系统的干预措施中,并在心血管疾病的管理中显示出广阔的前景。利用三维成像技术,SRT可以精确地定位交感神经节,并输送高能辐射以破坏神经纤维,从而在减少手术相关并发症并缩短恢复时间的同时,取得与传统交感神经切除术相似的效果。它还具有非侵入性和副作用较少的优点,因此在未来有潜力成为传统方法的替代方案。SRT与交感神经切除术的结合为心血管疾病的治疗开辟了新途径,并展现出广阔的临床应用前景。